US gene therapy company Regenxbio’s clemidsogene lanparvovec has a plausible pathway to US Food and Drug Administration (FDA) ...

Today, the Supreme People’s Court in China made a positive decision concerning the intellectual property rights relating to ...

Indian pharma major Lupin Limited announced that it has entered into an exclusive license, supply and distribution agreement ...

US biopharma company Greenwich LifeSciences has announced an 80% reduction in breast cancer recurrence from its ongoing Phase ...

India’s Cipla Limited (BSE: 500087) announced the launch of Afrezza (insulin human) Inhalation Powder in India.

US biotech royalty aggregator XOMA Royalty Corp announced it has amended its collaboration, originally established in 2006, ...

The US Food and Drug Administration (FDA) has approved Nereus (tradipitant), an oral neurokinin-1 (NK-1) receptor antagonist, ...

With 2025's pharma M&A spend exceeding $150 billion—going by deals reported on by The Pharma Letter—the total was higher than ...

Chinese biopharma Hutchmed today announces that the New Drug Application (NDA) for savolitinib for the treatment of locally ...

The US Food and Drug Administration (FDA) spent much of 2025 in the spotlight. Through steady drug approvals, renewed ...

Privately-held Italian drugmaker Italfarmaco and Japanese drugmaker JCR Pharmaceuticals have announced an exclusive licensing ...

US biotech Ultragenyx Pharmaceutical saw its shares tumble over 43% to $19.41 yesterday, after it announced results from the ...